Despite the FDA commissioner’s promises of partnership and collaboration, personnel changes and continued federal cuts create ...

Shares U.S. Healthcare ETF tracks the performance of the Russell 1000 Health Care RIC 22.5/45 Capped Gross Index. Click here ...

The firms lead an investment valuing PCI Pharma at $10 billion, see the company benefiting from broader trends.

A new fight is brewing over the Medicare drug price negotiation program after the Trump administration proposed to consider ...

FHLC is a solid healthcare ETF, but VHT offers slightly better performance, liquidity, and diversification for a similar ...

AbbVie, Inc. ABBV and Bristol Myers Squibb BMY are leading drugmakers with broad and diverse portfolios and a global footprint. AbbVie is a global, diversified biopharmaceutical company with a ...

Slashing adverse drug reactions through pharmacogenetics and advanced AI could help rehabilitate the pharmaceutical ...

West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. It operates through the Proprietary Products ...

Sahu, S. K., & Agarwal, N. (2017). Inter-Firm Differences in Mergers and Acquisitions A Study of the Pharmaceutical Sector in India. Journal of Economic Studies, 44, 861-878.

European biotech ecosystem takes aim at changing the funding narrative European biotechs have historically struggled to find capital on the continent, but the funding ecosystem now aims to scale up.